drugset / Trial / NCT00353184
Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years
Terminated
27 enrolled
Washington University School of Medicine
Ambulatory Pediatric Association · collabAmerican Academy of Pediatrics · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Oral montelukast is helpful in chronic asthma. The purpose of this pediatric study was to investigate whether the addition of oral montelukast to standard therapy for acute asthma exacerbations results in further improvement in breathing function over three hours.
Timeline
- Start
- 2001-09
- Primary completion
- 2004-10
- Completion
- 2005-02
Outcome
Outcome not reported
Stopped: “Results of the interim analysis suggested no significant diff between study groups.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 5 mg | Oral |